Goblet Cell Adenocarcinoma is a rare type of appendix cancer that has features of both gland-forming (adenocarcinoma) and neuroendocrine tumors.

​

Also Known As: Goblet Cell Carcinoid

​

You may see this condition referred to as “goblet cell carcinoid,” especially in older reports or online resources.

This is an outdated term.

​

Today, this condition is more accurately called Goblet Cell Adenocarcinoma (GCA) because:

​

• It behaves more like a cancer than a typical carcinoid tumor

• It often requires more comprehensive treatment

• ​

If your report uses the term “goblet cell carcinoid,” it is referring to the same condition.

​

It behaves differently than typical mucinous tumors.

​

What This Means

​

GCA tends to be more aggressive than LAMN or HAMN.

​

It often spreads earlier and may involve:

​

• The lining of the abdomen

• Lymph nodes

• In women, the ovaries

​

Because of this, treatment is often more proactive.

​

​Symptoms

​

Symptoms may include:

​

• Abdominal pain or cramping

• Changes in bowel habits

• Bloating

• In women, ovarian masses or pelvic symptoms

​

Some cases are found during appendectomy.

​

How It's Diagnosed

​

Diagnosis involves:

​

• Appendectomy or surgical biopsy

• Detailed pathology review

• Imaging (CT scans) to check spread

• Additional evaluation depending on findings

​​

​Treatment Options

​​

Treatment is typically more aggressive due to how this tumor behaves.

​

Options may include:

​

• Right hemicolectomy (removal of part of the colon)

• Systemic chemotherapy

• In some cases, CRS/HIPEC

• Care coordinated by oncology specialists

​

Prognosis & Outlook

​

Outcomes depend on stage and spread.

​

Because GCA behaves differently than other appendix tumors, early and specialized care is especially important.